Dear Almost, Many soon-to-be retirees are a bit blurry with what Medicare does and doesn’t cover when it comes to vision care ...

Q1 2025 Earnings Call Transcript April 30, 2025 Glaukos Corporation beats earnings expectations. Reported EPS is $-0.22, ...

IRIDEX has plenty of cash following a $10M strategic investment and the company is drastically cutting S&M spend. Click here ...

Advancements like SLT (selective laser trabeculoplasty) have reshaped glaucoma treatment, improving patient outcomes compared ...

The Sokoto State Government has commenced free cataract and glaucoma extraction surgeries for vulnerable residents across the ...

Specific visual field loss patterns are associated with a patient's higher risk for different glaucoma subtypes.

The IOP lowering power of 240° and 360° goniotomy (GT) is superior to 120° GT in the treatment of juvenile-onset glaucoma.

Christine Funke, MD, spoke about the role of doctors in making sure their patients are receiving proper care after being diagnosed with glaucoma.

Gland Pharma has received USFDA approval for its generic Latanoprostene Bunod Ophthalmic Solution, intended to treat high eye ...

Dr. Sabita Ittoop of Eye Specialists and Surgeons of Northern Virginia joined Good Morning Washington to talk about Glaucoma.

BEDFORD, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced ...

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.